32013138|t|Cerium Oxide Nanoparticles Rescue alpha-Synuclein-Induced Toxicity in a Yeast Model of Parkinson's Disease.
32013138|a|Over the last decades, cerium oxide nanoparticles (CeO2 NPs) have gained great interest due to their potential applications, mainly in the fields of agriculture and biomedicine. Promising effects of CeO2 NPs are recently shown in some neurodegenerative diseases, but the mechanism of action of these NPs in Parkinson's disease (PD) remains to be investigated. This issue is addressed in the present study by using a yeast model based on the heterologous expression of the human alpha-synuclein (alpha-syn), the major component of Lewy bodies, which represent a neuropathological hallmark of PD. We observed that CeO2 NPs strongly reduce alpha-syn-induced toxicity in a dose-dependent manner. This effect is associated with the inhibition of cytoplasmic alpha-syn foci accumulation, resulting in plasma membrane localization of alpha-syn after NP treatment. Moreover, CeO2 NPs counteract the alpha-syn-induced mitochondrial dysfunction and decrease reactive oxygen species (ROS) production in yeast cells. In vitro binding assay using cell lysates showed that alpha-syn is adsorbed on the surface of CeO2 NPs, suggesting that these NPs may act as a strong inhibitor of alpha-syn toxicity not only acting as a radical scavenger, but through a direct interaction with alpha-syn in vivo.
32013138	0	12	Cerium Oxide	Chemical	MESH:C030583
32013138	34	49	alpha-Synuclein	Gene	6622
32013138	58	66	Toxicity	Disease	MESH:D064420
32013138	72	77	Yeast	Species	4932
32013138	87	106	Parkinson's Disease	Disease	MESH:D010300
32013138	131	143	cerium oxide	Chemical	MESH:C030583
32013138	159	163	CeO2	Chemical	MESH:C030583
32013138	307	311	CeO2	Chemical	MESH:C030583
32013138	343	369	neurodegenerative diseases	Disease	MESH:D019636
32013138	415	434	Parkinson's disease	Disease	MESH:D010300
32013138	436	438	PD	Disease	MESH:D010300
32013138	524	529	yeast	Species	4932
32013138	580	585	human	Species	9606
32013138	586	601	alpha-synuclein	Gene	6622
32013138	603	612	alpha-syn	Gene	6622
32013138	638	649	Lewy bodies	Disease	MESH:D020961
32013138	699	701	PD	Disease	MESH:D010300
32013138	720	724	CeO2	Chemical	MESH:C030583
32013138	745	754	alpha-syn	Gene	6622
32013138	763	771	toxicity	Disease	MESH:D064420
32013138	861	870	alpha-syn	Gene	6622
32013138	935	944	alpha-syn	Gene	6622
32013138	951	953	NP	Chemical	MESH:D009405
32013138	975	979	CeO2	Chemical	MESH:C030583
32013138	999	1008	alpha-syn	Gene	6622
32013138	1017	1042	mitochondrial dysfunction	Disease	MESH:D028361
32013138	1056	1079	reactive oxygen species	Chemical	MESH:D017382
32013138	1081	1084	ROS	Chemical	MESH:D017382
32013138	1100	1105	yeast	Species	4932
32013138	1167	1176	alpha-syn	Gene	6622
32013138	1207	1211	CeO2	Chemical	MESH:C030583
32013138	1276	1285	alpha-syn	Gene	6622
32013138	1286	1294	toxicity	Disease	MESH:D064420
32013138	1373	1382	alpha-syn	Gene	6622
32013138	Association	MESH:D010300	6622
32013138	Negative_Correlation	MESH:C030583	MESH:D010300
32013138	Negative_Correlation	MESH:C030583	MESH:D064420
32013138	Association	MESH:D028361	6622
32013138	Negative_Correlation	MESH:C030583	6622
32013138	Positive_Correlation	MESH:D064420	6622
32013138	Association	MESH:D020961	6622
32013138	Negative_Correlation	MESH:C030583	MESH:D017382
32013138	Negative_Correlation	MESH:D009405	6622
32013138	Negative_Correlation	MESH:C030583	MESH:D019636
32013138	Negative_Correlation	MESH:C030583	MESH:D028361

